437 related articles for article (PubMed ID: 24667162)
1. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential.
Klinkhammer BM; Kramann R; Mallau M; Makowska A; van Roeyen CR; Rong S; Buecher EB; Boor P; Kovacova K; Zok S; Denecke B; Stuettgen E; Otten S; Floege J; Kunter U
PLoS One; 2014; 9(3):e92115. PubMed ID: 24667162
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells.
Kim H; Yu MR; Lee H; Kwon SH; Jeon JS; Han DC; Noh H
Aging Cell; 2021 Feb; 20(2):e13317. PubMed ID: 33524231
[TBL] [Abstract][Full Text] [Related]
4. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.
van Koppen A; Joles JA; van Balkom BW; Lim SK; de Kleijn D; Giles RH; Verhaar MC
PLoS One; 2012; 7(6):e38746. PubMed ID: 22723882
[TBL] [Abstract][Full Text] [Related]
5. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.
da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N
Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732
[TBL] [Abstract][Full Text] [Related]
6. Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats.
Yamada A; Yokoo T; Yokote S; Yamanaka S; Izuhara L; Katsuoka Y; Shimada Y; Shukuya A; Okano HJ; Ohashi T; Ida H
Hum Cell; 2014 Apr; 27(2):59-67. PubMed ID: 24496821
[TBL] [Abstract][Full Text] [Related]
7. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins.
Yoon YM; Lee JH; Song KH; Noh H; Lee SH
J Pineal Res; 2020 Apr; 68(3):e12632. PubMed ID: 31989677
[TBL] [Abstract][Full Text] [Related]
8. Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP
Han YS; Kim SM; Lee JH; Jung SK; Noh H; Lee SH
J Pineal Res; 2019 Jan; 66(1):e12535. PubMed ID: 30372554
[TBL] [Abstract][Full Text] [Related]
9. Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease.
van Rhijn-Brouwer FCC; van Balkom BWM; Papazova DA; Hazenbrink DHM; Meijer AJ; Brete I; Briceno V; van Zuilen AD; Toorop RJ; Fledderus JO; Gremmels H; Verhaar MC
Stem Cells Int; 2019; 2019():1232810. PubMed ID: 31933648
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
[TBL] [Abstract][Full Text] [Related]
12. The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease.
Sohi GK; Farooqui N; Mohan A; Rajagopalan KS; Xing L; Zhu XY; Jordan K; Krier JD; Saadiq IM; Tang H; Hickson LJ; Eirin A; Lerman LO; Herrmann SM
Stem Cell Res Ther; 2024 Jun; 15(1):162. PubMed ID: 38853239
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosis.
Isik B; Thaler R; Goksu BB; Conley SM; Al-Khafaji H; Mohan A; Afarideh M; Abumoawad AM; Zhu XY; Krier JD; Saadiq IM; Tang H; Eirin A; Hickson LJ; van Wijnen AJ; Textor SC; Lerman LO; Herrmann SM
Stem Cell Res Ther; 2021 Apr; 12(1):240. PubMed ID: 33853680
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease.
Wang Y; Guo YF; Fu GP; Guan C; Zhang X; Yang DG; Shi YC
Stem Cell Res Ther; 2020 Jul; 11(1):274. PubMed ID: 32641100
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
16. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.
Osugi M; Katagiri W; Yoshimi R; Inukai T; Hibi H; Ueda M
Tissue Eng Part A; 2012 Jul; 18(13-14):1479-89. PubMed ID: 22443121
[TBL] [Abstract][Full Text] [Related]
17. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stem cells transplantation ameliorates renal injury through anti-fibrotic and anti-inflammatory effects in chronic experimental renovascular disease.
Almeida A; Lira R; Oliveira M; Martins M; Azevedo Y; Silva KR; Carvalho S; Cortez E; Stumbo AC; Carvalho L; Thole A
Biomed J; 2022 Aug; 45(4):629-641. PubMed ID: 34333108
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis.
Lee JH; Yun CW; Hur J; Lee SH
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29642406
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
Qi S; Wu D
Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]